INDSWIFT LABORATORIES Financial Statement Analysis
|
||
|
The Revenues of INDSWIFT LABORATORIES have increased by 16.23% YoY .
The Earnings Per Share (EPS) of INDSWIFT LABORATORIES has increased by Positive YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
INDSWIFT LABORATORIES Last 5 Annual Financial Results
[BOM: 532305|NSE : INDSWFTLAB]
| Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
|---|---|---|---|---|---|
| Revenues | ₹1,207 Cr | ₹1,039 Cr | ₹891 Cr | ₹780 Cr | ₹757 Cr |
| Expenses | ₹978 Cr | ₹843 Cr | ₹709 Cr | ₹636 Cr | ₹630 Cr |
| Operating Profit (Excl OI) | ₹229 Cr | ₹196 Cr | ₹183 Cr | ₹143 Cr | ₹126 Cr |
| Other Income | ₹34 Cr | ₹43 Cr | ₹23 Cr | ₹33 Cr | ₹37 Cr |
| Interest | ₹92 Cr | ₹96 Cr | ₹100 Cr | ₹107 Cr | ₹92 Cr |
| Depreciation | ₹57 Cr | ₹131 Cr | ₹87 Cr | ₹90 Cr | ₹104 Cr |
| Profit Before Tax | ₹87 Cr | ₹13 Cr | ₹18 Cr | ₹-20 Cr | ₹50 Cr |
| Profit After Tax | ₹48 Cr | ₹-2.15 Cr | ₹-3.15 Cr | ₹-21 Cr | ₹29 Cr |
| Consolidated Net Profit | ₹48 Cr | ₹-2.15 Cr | ₹-3.15 Cr | ₹-21 Cr | ₹29 Cr |
| Earnings Per Share (Rs) | ₹8.06 | ₹-0.36 | ₹-0.53 | ₹-3.59 | ₹6.09 |
| PAT Margin (%) | 3.94 | -0.21 | -0.35 | -2.71 | 3.81 |
| ROE(%) | 10.61 | -0.54 | -0.78 | -5.56 | 8.99 |
| ROCE(%) | 13.25 | 7.88 | 8.31 | 5.97 | 9.25 |
| Total Debt/Equity(x) | 1.71 | 2.33 | 2.56 | 2.48 | 3.21 |
Key Financials |
||
| Market Cap | : | ₹ 735.3 Cr |
| Revenue (TTM) | : | ₹ 1,191.8 Cr |
| Net Profit(TTM) | : | ₹ 44.8 Cr |
| EPS (TTM) | : | ₹ 7.6 |
| P/E (TTM) | : | 16.4 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| INDSWIFT LABORATORIES | 5.1% | 20.2% | 86.4% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.1% | -2.8% | 50.3% |
| CIPLA | 4.5% | -3.1% | 52.8% |
| DR REDDYS LABORATORIES | 4.6% | 1.4% | 22.2% |
| ZYDUS LIFESCIENCES | 3.1% | -4.1% | 80.4% |
| DIVIS LABORATORIES | 4.7% | 10.8% | 18.1% |
| MANKIND PHARMA | 2.7% | 12.4% | NA |
| TORRENT PHARMACEUTICALS | 6.1% | 5.3% | 66.2% |
| LUPIN | 3.1% | -1.1% | 127.4% |
INDSWIFT LABORATORIES Revenues
[BOM: 532305|NSE : INDSWFTLAB]
| Y-o-Y | 16.23 % |
| 5 Yr CAGR | 12.39 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2023 | ₹1,207 Cr | 16.23 | |
| Mar2022 | ₹1,039 Cr | 16.54 | |
| Mar2021 | ₹891 Cr | 14.33 | |
| Mar2020 | ₹780 Cr | 3.05 | |
| Mar2019 | ₹757 Cr | - | |
INDSWIFT LABORATORIES Operating Profit
[BOM: 532305|NSE : INDSWFTLAB]
| Y-o-Y | 17.16 % |
| 5 Yr CAGR | 16.11 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2023 | ₹229 Cr | 17.16 | |
| Mar2022 | ₹196 Cr | 7.01 | |
| Mar2021 | ₹183 Cr | 27.41 | |
| Mar2020 | ₹143 Cr | 13.76 | |
| Mar2019 | ₹126 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 0.80 % |
| 5 Yr CAGR | 3.30 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2023 | 18.98% | 0.80 | |
| Mar2022 | 18.83% | -8.19 | |
| Mar2021 | 20.51% | 11.47 | |
| Mar2020 | 18.4% | 10.38 | |
| Mar2019 | 16.67% | - | |
INDSWIFT LABORATORIES Profit After Tax
[BOM: 532305|NSE : INDSWFTLAB]
| Y-o-Y | Positive |
| 5 Yr CAGR | 13.24 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2023 | ₹48 Cr | Positive | |
| Mar2022 | ₹-2.15 Cr | Negative | |
| Mar2021 | ₹-3.15 Cr | Negative | |
| Mar2020 | ₹-21 Cr | Negative | |
| Mar2019 | ₹29 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | Positive |
| 5 Yr CAGR | 0.84 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2023 | 3.94 % | Positive | |
| Mar2022 | -0.21 % | Negative | |
| Mar2021 | -0.35 % | Negative | |
| Mar2020 | -2.71 % | Negative | |
| Mar2019 | 3.81 % | - | |
INDSWIFT LABORATORIES Earnings Per Share (EPS)
[BOM: 532305|NSE : INDSWFTLAB]
| Y-o-Y | Positive |
| 5 Yr CAGR | 7.26 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2023 | ₹8.06 | Positive | |
| Mar2022 | ₹-0.36 | Negative | |
| Mar2021 | ₹-0.53 | Negative | |
| Mar2020 | ₹-3.59 | Negative | |
| Mar2019 | ₹6.09 | - | |
INDSWIFT LABORATORIES Return on Capital Employed (ROCE)
[BOM: 532305|NSE : INDSWFTLAB]
| Y-o-Y | 68.15 % |
| 5 Yr CAGR | 9.40 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2023 | 13.25% | 68.15 | |
| Mar2022 | 7.88% | -5.17 | |
| Mar2021 | 8.31% | 39.20 | |
| Mar2020 | 5.97% | -35.46 | |
| Mar2019 | 9.25% | - | |
INDSWIFT LABORATORIES Share Price vs Sensex
| Current Share Price | : | ₹124.4 |
| Current MarketCap | : | ₹ 735.3 Cr |
| Updated EOD on | : | Apr 25,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDSWIFT LABORATORIES | 5.1% |
20.2% |
86.4% |
| SENSEX | 1.3% |
2.6% |
24% |
INDSWIFT LABORATORIES related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about INDSWIFT LABORATORIES Financials
How the annual revenues of INDSWIFT LABORATORIES have changed ?
The Revenues of INDSWIFT LABORATORIES have increased by 16.23% YoY .
How the Earnings per Share (EPS) of INDSWIFT LABORATORIES have changed?
The Earnings Per Share (EPS) of INDSWIFT LABORATORIES has increased by Positive YoY .
Check out Intrinsic Value of Peers of INDSWIFT LABORATORIES
Compare Stock Analytics of Peers of INDSWIFT LABORATORIES
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
